For: | Wimmer E, Ihrler S, Gires O, Streit S, Issing W, Bergmann C. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World J Clin Oncol 2019; 10(3): 136-148 [PMID: 30949443 DOI: 10.5306/wjco.v10.i3.136] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i3/136.htm |
Number | Citing Articles |
1 |
Lluvia Sugey Sosa-Quintero, Sonia Guadalupe Barreno-Rocha, Sandra Guzmán-Silahua, Grecia Guadalupe Ornelas-Ibarra, Lluvia Giselle Demis-Eliseo, Benjamín Rubio-Jurado, Arnulfo Hernán Nava-Zavala. Biomarcadores serológicos de riesgo en linfoma no Hodgkin. Salud Jalisco 2023; 10(3): 164 doi: 10.35366/113307
|
2 |
Tao Peng, Yangyang Sun, Zhiwei Lv, Ze Zhang, Quanxin Su, Hao Wu, Wei Zhang, Wei Yuan, Li Zuo, Li Shi, Li-Feng Zhang, Xiaoli Zhou, Yuanyuan Mi. Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80146-y
|
3 |
Ju-Pi Li, Hsien-Cheng Huang, Po-Jen Yang, Chien-Yuan Chang, Yu-Hua Chao, Thomas Chang-Yao Tsao, Hsuan Huang, Yu-Ching Hung, Ming-Ju Hsieh, Shun-Fa Yang. FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan. International Journal of Environmental Research and Public Health 2020; 17(16): 5694 doi: 10.3390/ijerph17165694
|
4 |
Hailing Lin, Hongbo Fu, Shishen Sun, Hao Yin, Jie Yuan, Jilin Liao. Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing. Heliyon 2024; 10(10): e30985 doi: 10.1016/j.heliyon.2024.e30985
|
5 |
Zechen Wang, Karen S. Anderson. Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. The Cancer Journal 2022; 28(5): 354 doi: 10.1097/PPO.0000000000000615
|
6 |
Jung Han Kim, Soo Young Jeong, Hyun Joo Jang, Sung Taek Park, Hyeong Su Kim. FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.762528
|
7 |
Abdolkarim Moazeni-Roodi, Sahel Sarabandi, Shima Karami, Mohammad Hashemi, Saeid Ghavami. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer. Bioscience Reports 2020; 40(10) doi: 10.1042/BSR20192051
|